Enanta Pharmaceuticals Inc (ENTA NASDAQ) stock market data APIs
$8.2555
0.38(4.6%)
as of September 12, 2025
Try our APIs with
free plan!
Enanta Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. Enanta Pharmaceuticals, Inc. has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts.
Prev. Close
8.2555
Open
8.6378
High
8.9362
Low
8.2744
52 wk Range
4.09-13.3699
Market Cap
177 M
Shares Outstanding
21 378 K
Revenue
64 806 K
EPS
-0.85
Beta
0.845
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Enanta Pharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Enanta Pharmaceuticals Inc data using free add-ons & libraries
Get Enanta Pharmaceuticals Inc Fundamental Data
Enanta Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 64 806 K
- EBITDA: -93 036 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-11
- EPS/Forecast: -0.88
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Enanta Pharmaceuticals Inc News
New
Enanta CFO dies after taking medical leave of absence
This story was originally published on CFO Dive. To receive daily news and insights, subscribe to our free daily CFO Dive newsletter. Dive Brief: Enanta Pharmaceuticals CEO Jay Luly on Wednesday sai...
Does Enanta’s EU Lawsuit Over Paxlovid Shift the Bull Case for Pfizer (PFE)?
Enanta Pharmaceuticals has filed a patent infringement lawsuit against Pfizer and subsidiaries in the Unified Patent Court of the European Union, alleging that Pfizer’s COVID-19 antiviral Paxlovid i...
Enanta Files Patent Lawsuit Against Pfizer (PFE) Over COVID-19 Drug Paxlovid
Enanta Pharmaceuticals has initiated legal action against Pfizer over a patent infringement related to Paxlovid, targeting the company's operations across the EU. Over the last quarter, Pfizer's stock...
Pfizer sued by Enanta in EU over patent infringement related to COVID pill
Alexander Sikov/iStock via Getty Images Enanta Pharmaceuticals (NASDAQ:ENTA [https://seekingalpha.com/symbol/ENTA]) announced on Wednesday a lawsuit filed in the EU against Pfizer (NYSE:PFE [https://...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
